These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 20600494
1. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Franco D, Li W, Qing F, Stoyanov CT, Moran T, Rice CM, Ho DD. Vaccine; 2010 Aug 09; 28(35):5676-85. PubMed ID: 20600494 [Abstract] [Full Text] [Related]
2. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. Abaitua F, Rodríguez JR, Garzón A, Rodríguez D, Esteban M. Virus Res; 2006 Mar 09; 116(1-2):11-20. PubMed ID: 16214252 [Abstract] [Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D. J Hum Virol; 2001 Mar 09; 4(6):306-16. PubMed ID: 12082397 [Abstract] [Full Text] [Related]
5. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost. Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K. Clin Immunol; 2006 Apr 09; 119(1):32-7. PubMed ID: 16458074 [Abstract] [Full Text] [Related]
8. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma. Gómez CE, Abaitua F, Rodríguez D, Esteban M. Virus Res; 2004 Sep 15; 105(1):11-22. PubMed ID: 15325077 [Abstract] [Full Text] [Related]
10. Immunogenicity of a new HIV-1 DNA construct in a BALB/c mouse model. Mahdavi M, Ebtekar M, Mahboudi F, Khorram Khorshid H, Rahbarizadeh F, Azadmanesh K, Darabi H, Pourasgari F, Hassan ZM. Iran J Immunol; 2009 Dec 15; 6(4):163-73. PubMed ID: 20054104 [Abstract] [Full Text] [Related]
18. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes. Dai K, Liu Y, Liu M, Xu J, Huang W, Huang X, Liu L, Wan Y, Hao Y, Shao Y. Vaccine; 2008 Sep 15; 26(39):5062-71. PubMed ID: 18573290 [Abstract] [Full Text] [Related]